Tramiprosate (Alzhemed) for Alzheimer's disease

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Mental health > Dementia & cognition > Interventions aimed at causes of the disease

Mental health > Dementia & cognition > Interventions aimed at interrupting disease processes

Neurology > Dementia & cognition > Treatment aimed at interrupting disease processes

Neurology > Dementia & cognition > Treatment aimed at causes of the disease

Published:

3 August 2018

Authors:

Malouf R, Collins H

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Malouf R, Collins H. Tramiprosate (Alzhemed) for Alzheimer's disease. Cochrane Database of Systematic Reviews 2018, Issue 8. Art. No.: CD007549. DOI: 10.1002/14651858.CD007549.pub2